Skip to content
GenoLensGenoLens

ALDH5A1

Chr 6p22.3

aldehyde dehydrogenase 5 family member A1

Aliases:
SSADH, SSDH
MANE:
ENST00000357578.8

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Ataxia and cerebellar anomalies - narrow panel

    BIALLELIC, autosomal or pseudoautosomal
  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Early onset or syndromic epilepsy

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Neurotransmitter disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Undiagnosed metabolic disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Childhood onset dystonia, chorea or related movement disorder

+1 more panels — install the extension to see the full list inline on any page.

Disease associations (Open Targets)

  • succinic semialdehyde dehydrogenase deficiency

    0.84
  • epilepsy

    0.61
  • bipolar disorder

    0.61
  • Seizure

    0.60
  • major depressive disorder

    0.57
  • hereditary disease

    0.52
  • migraine disorder

    0.52
  • Generalized non-motor (absence) seizure

    0.47
  • complex partial epilepsy

    0.46
  • bipolar I disorder

    0.39

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Succinate-semialdehyde dehydrogenase, mitochondrial

Catalyzes one step in the degradation of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA)

Curated MONDO disease pages that list ALDH5A1 among their top associated genes.

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.